Hematologic Adverse Events

Hematologic Adverse Events is a clinical phenomenon characterized as an unintended pathological disruption in blood cell production or function, specifically distinguished by abnormalities in hematopoietic parameters such as anemia, neutropenia, thrombocytopenia, or leukopenia arising during therapeutic intervention or disease progression.

382

Publications

17.6K

Citations

2.9K

Authors

1.1K

Institutions

Publications per year

2017–2026

87

Authors

2.9K

  1. VG
    Vikas Gupta

    Princess Margaret Cancer Centre, Canada

    4 publications · 350 citations

    4

    h-index

  2. SV
    Srđan Verstovšek

    The University of Texas MD Anderson Cancer Center, United States

    3 publications · 301 citations

    3

    h-index

  3. JM
    Joel M. Gore

    University of Massachusetts Chan Medical School, United States

    3 publications · 218 citations

    3

    h-index

  4. MT
    Moshe Talpaz

    The University of Texas MD Anderson Cancer Center, United States

    3 publications · 170 citations

    3

    h-index

  5. JE
    Jörge E. Cortes

    The University of Texas MD Anderson Cancer Center, United States

    3 publications · 227 citations

    3

    h-index

1–5 of 2.9K

Venues

  1. PubMed

    Repository · 30 publications · 769 citations

    15

    h-index

  2. Bone Marrow Transplantation

    14 publications · 758 citations

    13

    h-index

  3. Journal of Clinical Oncology

    13 publications · 973 citations

    11

    h-index

  4. Haematologica

    9 publications · 651 citations

    9

    h-index

  5. Annals of Pharmacotherapy

    8 publications · 184 citations

    8

    h-index

1–5